Sight Sciences is a medical device company that uses a computer-based device designed for the treatment of eye disease.
Sight Sciences has raised $35.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in January 2024.
Sight Sciences's investors include Hercules Capital, MidCap Financial, D1 Capital Partners, KCK, Scientific Health Development Partners.
Sight Sciences is headquartered in Menlo Park, United States.
Sight Sciences is a medical device company that uses a computer-based device designed for the treatment of eye disease.
Sight Sciences is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sight Sciences — Funding & Investors." VCBacked, January 23, 2024, https://www.vcbacked.co/company/sight-sciences. Accessed September 30, 2026.
VCBacked. (2024). Sight Sciences — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/sight-sciences
{{cite web |title=Sight Sciences — Funding & Investors |url=https://www.vcbacked.co/company/sight-sciences |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated